Publicações dos Sócios

2021

Impact of liver test abnormalities and chronic liver disease on the clinical outcomes of patients hospitalized with covid-19
Garrido M, Guedes TP, Silva JA, et al.
GE Port J Gastroenterol. 2021;28(4):253-264.
doi:10.1159/000513593
descarregue aqui pdf

Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease
Vuille-Lessard É, Rodrigues SG, Berzigotti A.
Clin Liver Dis. 2021;25(2):253-289.
doi:10.1016/j.cld.2021.01.005
descarregue aqui pdf

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Pons M, Augustin S, Scheiner B, et al.
Am J Gastroenterol. 2021;116(4):723-732.
doi:10.14309/ajg.0000000000000994
LINK

A single cell gene expression atlas of 28 human livers
Brancale J, Vilarinho S.
J Hepatol. Published online 2021.
doi:10.1016/j.jhep.2021.03.005
descarregue aqui o pdf

Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease
Cortez‐Pinto H, Liberal R, Lopes S, et al.
United Eur Gastroenterol J. 2021;(March):1-8.
doi:10.1002/ueg2.12095
descarregue aqui o pdf

Established and novel therapeutic options for autoimmune hepatitis
Liberal R, de Boer YS, Heneghan MA.
Lancet Gastroenterol Hepatol. 2021;6(4):315-326.
doi:10.1016/S2468-1253(20)30328-9
LINK

Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease
Lackner C, Stauber RE, Davies S, et al.
J Hepatol. Published online 2021.
doi:10.1016/j.jhep.2021.05.029
LINK

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
Costa D, Simbrunner B, Jachs M, et al.
J Hepatol. 2021;74(4):819-828.
doi:10.1016/j.jhep.2020.10.004
descarregue aqui o pdf

Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding
Kumar R, Kerbert AJC, Sheikh MF, et al.
J Hepatol. 2021;74(1):66-79.
doi:10.1016/j.jhep.2020.06.010
LINK

Burden of Liver Cirrhosis in Portugal between 2010 and 2017
Silva JM, Silva MJ, Calinas F, Nogueira PJ.
GE Port J Gastroenterol. 2021;28(3):153-161.
doi:10.1159/000510729
descarregue aqui o pdf

Optic Nerve Sheath Diameter in Acute Liver Failure: A Prospective Cohort Study
Cardoso FS, Pereira R, Moreno R, et al.
GE Port J Gastroenterol. 2021;28(3):170-178.
doi:10.1159/000511646
descarregue aqui o pdf

Long-Term Follow-Up of a Portuguese Single-Centre Cohort of Persons with Haemophilia and Hepatitis C Virus Infection
Pereira Guedes T, Garrido M, Kuttner Magalhães R, et al.
GE Port J Gastroenterol. 2021;28(2):79-86.
doi:10.1159/000510023
descarregue aqui o pdf

2020

Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis
Mendoza YP, Rodrigues SG, Bosch J, Berzigotti A.
Dig Liver Dis. 2020;52(9):958-965.
doi:10.1016/j.dld.2020.06.048
LINK

Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complication
Will V, Rodrigues SG, Stirnimann G, et al.
United Eur Gastroenterol J. 2020;8(8):961-969.
doi:10.1177/2050640620938525
descarregue aqui o pdf

Beta-blockers in cirrhosis: Evidence-based indications and limitations
Rodrigues SG, Mendoza YP, Bosch J.
JHEP Reports. 2020;2(1):100063.
doi:10.1016/j.jhepr.2019.12.001
descarregue aqui o pdf

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Trebicka J, Fernandez J, Papp M, et al.
J Hepatol. 2020;73(4):842-854.
doi:10.1016/j.jhep.2020.06.013
descarregue aqui o pdf

Elimination of Hepatitis C in Portugal: An Urban Legend?
Velosa J, Macedo G.
GE Port J Gastroenterol. 2020;27(3):166-171.
doi:10.1159/000505582
descarregue aqui o pdf

Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
Guedes TP, Fragoso P, Lemos C, et al.
GE Port J Gastroenterol. 2020;27(3):149-159.
doi:10.1159/000503074
descarregue aqui o pdf

Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity
Martins P, Verdelho Machado M.
GE Port J Gastroenterol. 2020;27(2):103-114.
doi:10.1159/000501405
descarregue aqui o pdf

Palliative Care in End-Stage Liver Disease Patients Awaiting Liver Transplantation: Review
Silva SV, Freire E, Pessegueiro Miranda H.
GE Port J Gastroenterol. 2020;27(6):417-428.
doi:10.1159/000507336
descarregue aqui o pdf

Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension
Santos S, Dantas E, Veloso Gomes F, et al.
GE Port J Gastroenterol. 2020;28(1):5-12.
doi:10.1159/000507894
descarregue aqui o pdf

APEF - ASSOCIAÇÃO PORTUGUESA PARA O ESTUDO DO FÍGADO
Rua Abranches Ferrão, nº 10 - 14º
1600-001 Lisboa Tel: 217995536 
Fax: 217995538
geral@apef.com.pt

Horário de funcionamento:
9.00 - 13.00, 14.00 - 18.00

Secretariado

Luis Maco
Diretor-Geral
luis.maco@apef.com.pt
Andreia Neto
andreia.neto@apef.com.pt
Teresa Jorge
teresa.jorge@apef.com.pt
Cândida Rodrigues

Tornar-se sócio

É favor enviar ao Presidente da APEF, até 3 meses da data da Assembleia Geral, a proposta devidamente preenchida, assinada por dois sócios titulares da APEF e acompanhada das notas curriculares (resumo cv), para: Geral@apef.com.pt ou para

APEF - ASSOCIAÇÃO PORTUGUESA PARA O ESTUDO DO FÍGADO, Rua Abranches Ferrão

Nº10 - 14º 1600-001 Lisboa.

Ficha de Inscrição